L282-0735 Screening compound: 3-(2-bromophenyl)-1-[4-({5-ethyl-2-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}sulfanyl)phenyl]urea

L282-0735 Screening compound: 3-(2-bromophenyl)-1-[4-({5-ethyl-2-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}sulfanyl)phenyl]urea
L282-0735 Screening compound: 3-(2-bromophenyl)-1-[4-({5-ethyl-2-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}sulfanyl)phenyl]urea alternative view

Chemical Structure Depiction of ChemDiv screening compound L282-0735
3-(2-bromophenyl)-1-[4-({5-ethyl-2-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}sulfanyl)phenyl]urea

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L282-0735

Molecular Formula

C21H19BrN6OS (C21 H19 BrN6 OS)

Compound Name

3-(2-bromophenyl)-1-[4-({5-ethyl-2-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}sulfanyl)phenyl]urea

IUPAC name

3-(2-bromophenyl)-1-[4-({5-ethyl-2-methyl-[124]triazolo[15-a]pyrimidin-7-yl}sulfanyl)phenyl]urea

SMILES

CCc1nc2nc(C)nn2c(Sc(cc2)ccc2NC(Nc(cccc2)c2Br)=O)c1

InChI

InChI=1S/C21H19BrN6OS/c1-3-14-12-19(28-20(24-14)23-13(2)27-28)30-16-10-8-15(9-11-16)25-21(29)26-18-7-5-4-6-17(18)22/h4-12H,3H2,1-2H3,(H2,25,26,29)

InChI Key

CFASPJJTLUTRJB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27239705

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

483.39

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.172

Distribution Coefficient, logD

5.172

Water Solubility, LogSw

-4.94

Polar Surface Area

62.715

Acid Dissociation Constant (pKa)

12.57

Base Dissociation Constant (pKb)

3.68

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

14.30

L282-0735 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Immunological Library (6760 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with L282-0735 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L282-0735?
Check Price and Availability of L282-0735, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L282-0735 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L282-0735
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L282-0735
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L282-0735 available by request